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Abstract:
Background: Pyoderma is common in India and
other tropical countries. Staphylococcus
aureus is the commonest causative agent of
pyoderma. Aims and Objectives: To know the
antibiotic susceptibility and bacteriophage
pattern of Staphylococcus aureus isolated
from pyoderma infection. Materials and
Methods: One hundred clinically diagnosed
pyoderma cases were investigated
bacteriologically. A total of 59 isolates of S.
aureus were subjected to antibiotic
susceptibility testing by Kirby Bauers disk
diffusion method and phage typing by routine
test dilution X 100 bacteriophages.
Results: Most of the strains were resistant to
penicillin, ampicillin and were susceptible to
gentamicin, streptomycin and erythromycin.
Multidrug resistance was also high among these
strains. Regarding the phage types, Phage type
52 (15 strains), 96 (8 strains) and 71(16
strains) were predominant among the typed
strains (55.95%) of S. aureus. The most
common group was mixed phage group (17%)
followed by phage group I (13.55%).
Conclusion: Knowledge of antibiotic
susceptibility pattern is essential to give proper
antibiotic therapy and avoid unnecessary
medication with non-effective drugs, which
may increase resistance. Gentamicin,
streptomycin and erythromycin are the drugs
of choice in that order. Association of phage
typing and antibiotic sensitivity of S. aureus
showed the predominance of phage group III
with greater frequency of penicillin resistance.
Key Words: pyoderma, Staphylococcus
aureus, multidrug resistance, phage typing
Introduction:
Pyoderma is a common bacterial skin
infection accounting for nearly 25% of patients
attending dermatology OPD in India and other
tropical countries [1].  Staphylococcus aureus
is a versatile organism and is the commonest
causative agent of pyoderma [2, 3]. Emergence
of multidrug resistant Staphylococcus aureus
has led to treatment failure in pyodermal
infection; hence a detailed knowledge of
antibiotic susceptibility pattern should be
available for treatment. Certain phage types of
S. aureus are more commonly associated with
pyoderma and vary at different places [4]. The
present study was undertaken to determine
antibiotic susceptibility, prevalent phage type
pattern of S. aureus in this area, to select the
antibiotics to treat the patient and for
epidemiological study.
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Materials and methods:
A total of 100 clinically diagnosed cases of
pyoderma who had not taken any systemic
antibiotics or applied any topical preparations
for the past one month, were included in this
study. The present study was conducted at
department of microbiology, Dr. V. M. Govt.
Medical College, Solapur, (Maharashtra), India
and approved by ethical clearance committee
of our institute. After taking informed consent
pus samples were collected under aseptic
precautions. Samples were processed for
Grams stain and inoculated on blood agar and
MacConkeys agar. The characteristic colonies
were identified by standard methods. Out of 100
clinical specimens a total 59 strains were
isolated and identified as S. aureus. These
strains were subjected for antibiotic
susceptibility testing and phage typing.
Antibiotic sensitivity of each S. aureus strain
was determined by Kirby Bauers disk diffu-
sion method on Muller-Hinton agar, using the
following antibiotic discs: Penicillin,
ampicillin, cotrimoxazole, chloramphenicol,
cefazolin, tetracycline, neomycin,
streptomycin, erythromycin and gentamicin. In
each test, S. aureus ATCC 25923 strain was
used as control [5]. All the isolated S. aureus
strains were sent for bacteriophage typing at the
Staphylococcal phage typing Center, Dept. of
Microbiology, Maulana Azad Medical
College, New Delhi. The typing was done
employing 23 sets of phages, in a routine test
dilution (RTD) X 100.
Results:
A total of 59 strains of S. aureus were isolated
from 100 pus samples of pyoderma cases. Of
the 59 strains, 58 (98.30%) were resistant to
penicillin and 48 (81.35%) were resistant to
ampicillin (Table-1).
Table 1: Antimicrobial resistance pattern of 59 Staphylococcus aureus strains isolated from
pyoderma.
Antibiotics Susceptible (%) Resistance (%)
Penicillin (10 units/disc)
Ampicillin (10 µg/disc),
Cotrimoxazole (10 µg/disc)
Chloramphenicol (30 µg/disc)
Cefazolin (30 µg/disc)
Tetracycline (30 µg/disc)
Neomycin (30 µg/disc)
Streptomycin (10 µg/disc)
Erythromycin (15 µg/disc)
Gentamicin (15 µg/disc)
01 (01.7)
11 (18 .7)
18 (30.5)
25 (42.4)
32 (54.3)
36 (61)
37 (62.7)
42 (71.2)
31 (69.5)
54 (91.5)
58 (98.3)
48 (81.3)
41 (69.5)
34 (57.6)
27 (45.7)
23 (39)
22 (37.3)
17 (28.8)
28 (30.5)
05 (08.5)
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Table 2: Distribution of phage patterns of Staphylococcus aureus among the pyoderma
cases.
Phage group
I
II
III
Miscellaneous
Mixed
Total typable
Number of
Isolates (%) Phage type (number isolates) at R.T.D. X 100
8 (13.55)
7 (11.80)
6 (10.15)
2 (03.45)
10 (17.00)
33 (55.95)
52 (4), 52A (1), 52/80 (1), 29/52/80 (1), 79 (1).
71 (4), 3A (1), 3C (1), 3C/71 (1).
75 (2), 42E (1), 83A/85 (1), 47/54/75 (1), 42E/83A/85 (1).
96 (2).
52/96 (2), 52/77/96 (1), 29/52/79/81 (1), 42E/81 (1),
29/52/81 (1), 52/42E/96 (1), 29/52/80/83A /85 (1),
52/53/71/96 (1), 52/52A/81/83/96 (1),
There was not a single strain which was
resistant to less than two antibiotics out of ten
antibiotics studied. Only 5 (08.47%) strains
were resistant to any two antibiotics.
Remaining 54 strains were either resistant to
any three (16.95%), four (20.34%), five
(22.04%) or more number (32.20%) of
antibiotics. In our study, 44 (74.58%) strains
were resistant to more than three antibiotics.
Out of 59 isolates of S. aureus, 33 (55.95%)
strains were typable and remaining 26
(44.05%) were non-typable. The most common
group was mixed phage group (17%) followed
by phage group I (13.55%). Phage type 52 (15
strains), 96 (8 strains) and 71 (16 strains) were
predominant among the typed strains of
S. aureus (Table-2).
Discussion:
Among the 100 cases of pyoderma, S. aureus
has been responsible for 59 cases. These
isolates have shown resistance to penicillin,
ampicillin, as well as tetracycline. The
antimicrobial susceptibility pattern has revealed
that gentamicin has been the most effective drug
against S. aureus followed by streptomycin and
erythromycin. Other workers have also
reported the same observations [6-7]. Bhat KG
et al [2] has reported that gentamicin and
cloxacillin are the most effective antibiotics
against S. aureus causing pyodermal infection,
while Ramani TV et al [3] has reported that S.
aureus strains have been more susceptible to
erythromycin [6] and kanamycin. Now
penicillin resistance is a well known
phenomenon. The highest resistance has been
observed to penicillin (98.30%) followed by
ampicillin (81.35%). Same antibiotic
resistance pattern has been reported in many
studies [1-2, 6-9].
Multidrug resistant (MDR) S. aureus among
the pyoderma cases are very high. Majority of
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MDR strains are isolated from superficial
infections [10]. There are many reports from
our country regarding the increase in resistance
in S. aureus. Multiple drug resistance in S.
aureus of 56.5% has been reported by Kar PK
et al [9]. The mechanisms of multidrug
resistance in S. aureus are drug inactivation or
modification due enzymatic deactivation and
alteration of target by the bacteria. The
production of penicillinase, phosphotransferase,
acetyltransferase and adenyltransferase
enzymes are capable of inactivating the
antibiotics [10]. These characters are probably
plasmid borne. S. aureus may acquire
vancomycin resistance gene (plasmid) through
conjugation from enterococci [11]. There is a
possibility of a circulating pool of genes that
transcend species barrier and determine
antibiotic resistance [12]. So, the strains
isolated from clinical specimens should be
tested at least for penicillinase production.
Penicillinase producing S. aureus infections
can be treated with penicillinase resistant
penicillins [2].
The modes of acquisition of antibiotic
resistance by S. aureus and possible
ecological effects have also been reviewed [10].
In India multiple drug resistance  is probably
due to indiscriminate use of antibiotics
(isoxazoyl penicillin), inadequate investigation
facilities and lack of proper antibiotic policy
in clinical practice. Many studies have
demonstrated a decrease in multiresistance
over a period, by controlling these three
factors that seem to have made a major dent on
the problem [10, 12].
Treatment of staphylococcal infections is
becoming increasingly difficult in view of the
widespread presence of MDR strains. [13].
Bacteriophages have been found to be a
significant vector of antibiotic-resistance.
Strains lysogenic for phage 188 acquire both
chromosome and plasmid-determined
resistance markers and the lysis of the donor
cells is apparently required for the acquisition
of resistance determinants [14].
The bacteriophage typing is used as a precise
identification method of S. aureus and has
provided valuable information in
epidemiological studies of infection in the
community [4]. The bacteriophage typing of S.
aureus strains revealed that, the most common
pattern is mixed (17%), as these particular
organisms lysed by phages belonging to more
than one group. Phage group I has been
common in isolates from hospital acquired and
endemeic infections, is the major group
(13.55%) in our study. Antibiotic resistant
strains usually belong to phage group III. In our
study, 40.20% penicillin resistant strains
belonged to phage group III. Similar findings
have been noted with tetracycline and
streptomycin [3]. The strains probably harbour
plasmid(s) coding for resistance to penicillin
and tetracycline. There is a simultaneous loss
of a prophage carried in these strains [12]. Most
of the workers have reported predominance of
phage group III and II of S. aureus in pyoderma
cases in different studies in India and the
available reports from abroad. But in our study
only 10.15% strains have belonged to  phage
group III and 11.80% to groupII. There have been
only 02 (3.45%) strains in miscellaneous group
but this group is infrequent in other studies. The
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incidence of phage groups I, II, III and IV,
miscellaneous, mixed and non-typable has been
shown to varied from 1.2 to 24.9, 02 to 17.8,
and 12.4 to 30.00 to 2.6, 00 to 10.4, 4.1 to
25.2 and 29.4 to 56.3 percents respectively.
Such a wide variation in incidence has been
observed among various reports published at
different places and at different time by many
workers (3- 4, 8). Phage type 52 (15 strains)
has been very common followed by 96 (8
strains) and 71 (6 strains) in our study.
Non-typablility of S. aureus strains is a major
problem employing the available sets of
bacteriophages in India and other developing
countries [5]. In our study 26 (44.05%) strains
have been non-typable. This non-typability can
be reduced by using routine test dilution
strength and heat shock treatment before
phage typing of S. aureus. Bacterium can alter
its phage restricting activity, which is unlikely
to occur at 370C [15].
The treatment of bacterial infections with
bacteriophages is termed phage therapy [16].
The experimental phage therapy in animals and
humans suggests that phage therapy could be
an alternative to antibiotics for the treatment
of infections caused by MDR strains. Recently
Ryszard et al [17] have described a case of the
successful eradication of MRSA carrier status
in a healthcare worker. Moreover, they have
reported that, a significantly lower cost of
phage therapy constitutes an important
additional argument for its wider consideration
in the current era of a worldwide crisis due to
antibiotic resistance & the economics of healthcare.
The phage K has the ability to kill a broad [16]
range of newly isolated pathogenic MDR
staphylococci [18]; including both human and
veterinary strains and it could be valuable
prophylactic agent especially in
immunocompromised patients [19]. The phage
may be active against systemic, local and
intracellular bacterial infections. However,
bacterial strains may develop resistance to a
bacteriophage [13]. Nevertheless, elaborative
study on phage therapy in human is needed.
The present study concludes that Phage type 52
is very common. Association of phage typing
and antibiotic sensitivity of S. aureus has
showed the predominance of mixed phage group
with greater frequency of penicillin resistance.
Penicillin and ampicillin are the most non-
effective antibiotics against S. aureus causing
pyoderma. The increasing drug resistance is a
major obstacle in the treatment of S. aureus
infection. So the knowledge of antibiotic
susceptibility pattern is essential to give proper
antibiotic therapy and to avoid unnecessary
medication with non-effective drugs, which
may increase the resistance. We should improve
investigation facilities for the detection of
MDR bacteria, stop indiscriminate use of
antibiotics (isoxazoyl penicillin) and follow
proper antibiotic policy in clinical practice to
reduce acquired resistance by the bacteria like
S. aureus. Gentamicin, streptomycin and
erythromycin are the drugs of choice in that
order. These antibiotics can be recommended
for treatment of staphylococcal pyoderma, in
the situations where antibiotic sensitivity
testing is not possible or immediate report is
not available.
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